Hopkinson Craig C.
CIK 1730048
Transactions on file
37
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-01 | 2026-07-01 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Sale | 700 | $36.5K | -3.1% | open → |
| 2026-07-01 | 2026-07-01 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Sale | 8,300 | $427.1K | -1.9% | open → |
| 2026-07-01 | 2026-07-01 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Exer. | 5,000 | $96.7K | +161.1% | open → |
| 2026-06-01 | 2026-06-01 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Sale | 9,000 | $375.0K | +21.2% | open → |
| 2026-06-01 | 2026-06-01 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Exer. | 5,000 | $96.7K | +161.1% | open → |
| 2025-01-31 | 2025-01-30 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Exer. | 29,156 | $584.0K | +152.1% | open → |
| 2025-01-31 | 2025-01-30 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Exer. | 26,589 | $514.2K | +161.1% | open → |
| 2025-01-31 | 2025-01-30 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Exer. | 23,542 | $578.9K | +105.4% | open → |
| 2025-01-31 | 2025-01-30 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Sale | 100,918 | $3.23M | +57.6% | open → |
| 2025-01-31 | 2025-01-30 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Exer. | 18,345 | $492.0K | +88.3% | open → |
| 2025-02-07 | 2025-02-06 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Grant | 34,393 | — | — | open → |
| 2025-02-07 | 2025-02-06 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Tax | 15,083 | $473.5K | +60.9% | open → |
| 2025-02-14 | 2025-02-12 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Sale | 33,108 | $1.10M | +51.8% | open → |
| 2025-02-14 | 2025-02-13 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Sale | 35,586 | $1.21M | +48.4% | open → |
| 2025-02-14 | 2025-02-13 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Exer. | 35,586 | $875.1K | +105.4% | open → |
| 2025-02-14 | 2025-02-13 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Exer. | 108,833 | $3.48M | +58.2% | open → |
| 2025-02-14 | 2025-02-13 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Sale | 108,833 | $3.92M | +40.2% | open → |
| 2025-02-14 | 2025-02-12 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Sale | 171,813 | $5.62M | +54.5% | open → |
| 2025-02-14 | 2025-02-12 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Exer. | 111,630 | $2.16M | +161.1% | open → |
| 2025-02-14 | 2025-02-12 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Exer. | 87,566 | $1.75M | +152.1% | open → |
| 2025-02-20 | 2025-02-18 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Tax | 3,950 | $141.8K | +40.7% | open → |
| 2025-02-20 | 2025-02-18 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Exer. | 8,896 | — | — | open → |
| 2025-02-25 | 2025-02-22 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Tax | 5,452 | $192.6K | +43.0% | open → |
| 2025-02-25 | 2025-02-23 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Exer. | 7,689 | — | — | open → |
| 2025-02-25 | 2025-02-23 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Tax | 3,414 | $120.6K | +43.0% | open → |
| 2025-02-25 | 2025-02-22 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Exer. | 12,279 | — | — | open → |
| 2025-02-28 | 2025-02-26 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Exer. | 6,866 | — | — | open → |
| 2025-02-28 | 2025-02-26 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Tax | 3,049 | $106.1K | +45.1% | open → |
| 2026-05-02 | 2026-05-01 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Sale | 9,000 | $300.6K | +51.2% | open → |
| 2026-05-02 | 2026-05-01 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Exer. | 5,000 | $96.7K | +161.1% | open → |
| 2025-12-05 | 2025-12-03 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Sale | 3,748 | $112.4K | +68.3% | open → |
| 2025-12-05 | 2025-12-03 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Exer. | 3,748 | $72.5K | +161.1% | open → |
| 2025-12-01 | 2025-12-01 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Sale | 4,000 | $117.2K | +72.4% | open → |
| 2025-11-03 | 2025-11-03 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Sale | 9,000 | $273.4K | +66.2% | open → |
| 2025-11-03 | 2025-11-03 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Exer. | 5,000 | $96.7K | +161.1% | open → |
| 2025-10-15 | 2025-10-15 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Sale | 9,000 | $283.8K | +60.2% | open → |
| 2025-10-15 | 2025-10-15 | ALKS Alkermes plc. | Officer EVP R&D, Chief Medical Officer | Exer. | 5,000 | $96.7K | +161.1% | open → |
